Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients

Disseminated tumor cells (DTCs) in the bone marrow (BM) of breast cancer (BC) patients are putative precursors of metastatic disease, and their presence is associated with an adverse clinical outcome. To achieve the personalization of therapy on a clinical routine level, the characterization of DTCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Volmer, Léa L., Önder, Cansu E., Volz, Barbara, Singh, Anjali R., Brucker, Sara Y., Engler, Tobias, Hartkopf, Andreas D., Koch, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531360/
https://www.ncbi.nlm.nih.gov/pubmed/37762233
http://dx.doi.org/10.3390/ijms241813930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531360/
https://www.ncbi.nlm.nih.gov/pubmed/37762233
http://dx.doi.org/10.3390/ijms241813930

Ejemplares similares